| To: Jim Bishop who started this subject | 1/10/2002 3:37:45 PM | | From: SSP | of 150056 | | | CARA - INDIA'S SUN PHARMA US ARM RECEIVES APPROVAL FOR OXAPROZIN TAB
NEW DELHI, Jan 10, 2002 (AsiaPulse via COMTEX) -- Caraco Pharmaceutical
Laboratories, the US-based arm of Sun Pharmaceuticals Ltd (BSE:SUN), has
received US Food and Drug Administration approval to market and manufacture
Oxaprozin tablets, a generic version G. D Searle's anti-rheumatoid, 'Daypro'.
The total US market for Oxaprozin is estimated at US$168 million.
Detroit-based company last month received a letter of approvability for FDA to
produce metformin hydrochloride, a generic form of Bristol Myers Squibb's
anti-diabetic Glucophage.
"Caraco has 5 additional drugs pending FDA approval and expects to receive
approvals for the majority of these by year end," Narendra N Borkar, chief
executive officer, Caraco said in a statement here.
The company received FDA approval to manufacture and market
Carbamazepine(chewable), a generic form of Novartis' 'Tegretol', Clonazepam, a
generic form of Roche's 'Klonopin' and Flurbiprofen, a generic form of
Pharmacias's 'Ansaid' last year, statement added. |
| | TGL WHAAAAAAAT! Alerts, thoughts, discussion. | Stock Discussion ForumsShare | Recommend | Keep | Reply | Mark as Last Read | Read Replies (1) |
|
